BiomX (NYSEAMERICAN:PHGE – Get Free Report) will likely be posting its quarterly earnings results before the market opens on Wednesday, April 2nd. Analysts expect BiomX to post earnings of ($1.65) per share for the quarter.
BiomX Price Performance
Shares of PHGE opened at $0.56 on Tuesday. The stock has a market cap of $10.10 million, a price-to-earnings ratio of -0.17 and a beta of 1.27. BiomX has a 12 month low of $0.48 and a 12 month high of $4.99.
Analysts Set New Price Targets
Separately, HC Wainwright restated a “buy” rating and set a $2.00 target price on shares of BiomX in a research report on Wednesday, January 8th.
BiomX Company Profile
BiomX Inc, a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibrosis (CF), atopic dermatitis, and colorectal cancer (CRC).
Featured Articles
- Five stocks we like better than BiomX
- What Are Dividend Contenders? Investing in Dividend Contenders
- 3 Buyable Stocks With Solid Bottoms Ready to Rebound
- Learn Technical Analysis Skills to Master the Stock Market
- Advantage+ Shopping: Meta’s Fast Growing $20 Billion AI-Ads Star
- What is the S&P 500 and How It is Distinct from Other Indexes
- Robotaxi News: What Tesla and Lyft Headlines Mean for Shares
Receive News & Ratings for BiomX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BiomX and related companies with MarketBeat.com's FREE daily email newsletter.
